Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SmithKline Beecham's Lyme disease vaccine recommended for FDA approval

May 27, 1998

La Jolla Pharmaceutical develops commercial-scale process for LJP-394

May 27, 1998

Hyaluronate effective in preventing rejection in rat kidney allograft model

May 26, 1998

Pharmacokinetics and safety of SDZ-RAD reported at transplant meeting

May 25, 1998

Cystic fibrosis gene also protects against typhoid fever

May 25, 1998

Improved immunosuppression and synergistic effects described for malononitrilamides

May 22, 1998

Nicaraven shows promise for protecting liver transplants

May 22, 1998

Safety profile of ISIS-2302 in renal transplant patients

May 22, 1998

Results from phase II trial of Campylobacter vaccine

May 22, 1998

Icos begins phase I/II trial for antipsoriatic

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...